Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
The observation is procedural in nature and the company will address the observation within stipulated timelines.
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
The companies will leverage their respective proprietary technology platforms
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Subscribe To Our Newsletter & Stay Updated
